english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Strategic choices

Depression: possible increase in the risk of suicide with esketamine (Spravato°)

"Preventing Overdiagnosis 2022": an international conference to be held in Calgary, 9-12 June

Ozanimod (Zeposia°) in multiple sclerosis. As ineffective and probably as toxic as fingolimod

In the May issue of Prescrire International: Pertuzumab + trastuzumab (Phesgo°) by subcutaneous injection, in certain types of breast cancer

The EMA is withholding too much information

European Medicines Agency: insufficient transparency

Fostemsavir (Rukobia°) in multidrug-resistant HIV-1 infection

Pharmacobezoars may prolong effects of overdose

Prescrire's Solidarity Support Programme: facilitating access to reliable and independent information around the world

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90